[Stratified outcomes of "Kidney Disease: Improving Global Outcomes" serum creatinine criteria in critical ill patients: a secondary analysis of a multicenter prospective study].


Journal

Zhonghua wei zhong bing ji jiu yi xue
ISSN: 2095-4352
Titre abrégé: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
Pays: China
ID NLM: 101604552

Informations de publication

Date de publication:
Mar 2020
Historique:
entrez: 10 5 2020
pubmed: 10 5 2020
medline: 11 7 2020
Statut: ppublish

Résumé

To investigate the different outcomes of two types of acute kidney injury (AKI) according to standard of Kidney Disease: Improving Global Outcomes-AKI (KDIGO-AKI), and to analyze the risk factors that affect the prognosis of intensive care unit (ICU) patients in China. A secondary analysis was performed on the database of a previous study conducted by China Critical Care Clinical Trial Group (CCCCTG), which was a multicenter prospective study involving 3 063 patients in 22 tertiary ICUs in 19 provinces and autonomous regions of China. The demographic data, scores reflecting severity of illness, laboratory findings, intervention during ICU stay were extracted. All patients were divided into pure AKI (PAKI) and acute on chronic kidney disease (AoCKD). PAKI was defined as meeting the serum creatinine (SCr) standard of KDIGO-AKI (KDIGO-AKI Of the 3 063 patients, 1 042 were enrolled, 345 with AKI, 697 without AKI. The AKI incidence was 33.11%, while ICU mortality within 28 days of AKI patients was 13.91% (48/345). Compared with PAKI patients (n = 322), AoCKD patients (n = 23) were older [years old: 74 (59, 77) vs. 58 (41, 72)] and more critical when entering ICU [acute physiology and chronic health evaluation II (APACHE II) score: 23 (19, 27) vs. 15 (11, 22)], had worse basic renal function [eGFR (mL×min Further detailed classification (PAKI, AoCKD) based on KDIGO-AKI

Identifiants

pubmed: 32385995
doi: 10.3760/cma.j.cn121430-20200218-00192
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article Multicenter Study

Langues

chi

Sous-ensembles de citation

IM

Pagination

313-318

Auteurs

Guiying Dong (G)

Medical Intensive Care Unit, Peking Union Medical College Hospital, Beijing 100730, China.

Junping Qin (J)

Medical Intensive Care Unit, Tsinghua University Affiliated Beijing Tsinghua Changueng Hospital, Beijing 102218, China.

Youzhong An (Y)

Department of Critical Care Medicine, Peking University People's Hospital, Beijing 100044, China.

Yan Kang (Y)

Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.

Xiangyou Yu (X)

Department of Critical Care Medicine, First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China.

Mingyan Zhao (M)

Department of Critical Care Medicine, the First Affiliated Hospital, Harbin Medical University, Harbin 150081, Heilongjiang, China.

Xiaochun Ma (X)

Department of Critical Care Medicine, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning, China.

Yuhang Ai (Y)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.

Yuan Xu (Y)

Department of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100005, China.

Yushan Wang (Y)

Department of Emergency and Critical Care Medicine, the Second Hospital of Jilin University, Changchun 130000, Jilin, China.

Chuanyun Qian (C)

Department of Emergency Medicine and Medical Intensive Care Unit, the First Affiliated Hospital of Kunming Medical College, Kunming 650032, Yunnan, China.

Dawei Wu (D)

Department of Critical Care Medicine, Qilu Hospital, Shandong University, Jinan 250012, Shandong, China.

Renhua Sun (R)

Department of Critical Care Medicine, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang, China.

Shusheng Li (S)

Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China.

Zhenjie Hu (Z)

Department of Critical Care Medicine, Hebei Medical University Fourth Hospital, Shijiazhuang 050011, Hebei, China.

Xiangyuan Cao (X)

Department of Critical Care Medicine, Affiliated Hospital of Ningxia Medical University, Yinchuan 750004, Ningxia Hui Autonomous Region, China.

Fachun Zhou (F)

Department of Critical Care Medicine, the First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.

Li Jiang (L)

Department of Critical Care Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100038, China.

Jiandong Lin (J)

Department of Critical Care Medicine, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, China.

Erzhen Chen (E)

Department of Emergency Medicine, Ruijin Hospital, Shanghai Jiao Tong University, Shanghai 510370, China.

Tiehe Qin (T)

Department of Critical Care Medicine, Guangdong General Hospital, Guangzhou 510080, Guangdong, China.

Zhenyang He (Z)

Department of Critical Care Medicine, Hainan Provincial People's Hospital, Haikou 570311, Hainan, China.

Lihua Zhou (L)

Department of Critical Care Medicine, the Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010050, Inner Mongolia Autonomous Region, China. Corresponding author: Du Bin, Email: dubin98@gmail.com.

Bin Du (B)

Medical Intensive Care Unit, Peking Union Medical College Hospital, Beijing 100730, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH